FemPulse was featured in the February edition of MedTech Insights in an article titled “Neuromodulation Devices Stimulate Opportunities in Urology”. The article provided a comprehensive assessment of future innovation in the rapidly growing fields of neuromodulation for Overactive Bladder (OAB). While currently marketed devices provide effective therapy, they can be costly, invasive and require a significant time commitment from the patient. FemPulse was cited for its innovation intended to lower barriers to patient acceptance. The article highlights plans by the company to bring this life-changing therapy to millions of women around the world.
